Patents for A61P 17 - Drugs for dermatological disorders (106,455)
01/2005
01/26/2005CN1569207A Prescription for blackening hair and prolonging life and its preparation
01/26/2005CN1569205A Method for preparing and controlling the quality of Chinese medicinal soft capsule
01/26/2005CN1569202A Medicine for treating acne and preparation method thereof
01/26/2005CN1569193A Medicine for treating burns and scalds and without scar after its healing
01/26/2005CN1569188A Externally applied liquor for treating psoriasis
01/26/2005CN1569175A Chinese medicine for treating burn and frostbite
01/26/2005CN1569174A Chinese medicine for treating injury and wound
01/26/2005CN1569134A Zinc oil preparation for treating burn and scald and preparation process thereof
01/26/2005CN1569124A Medicine for treating scald and its preparing method
01/26/2005CN1569111A Burn treating cream
01/26/2005CN1569106A Medicine for treating psoriasis and its preparation method
01/26/2005CN1569103A Medicinal bolus with functions of generating hair by tonifying kidney and replenishing essence
01/26/2005CN1569091A Beautifying face pack of pure Chinese herb for preventing face skin disease
01/26/2005CN1569083A Prescription of beautifying dietetic lozenge
01/26/2005CN1569080A Natural Chinese herb composition for treating alopecia and leucotrichia and its application
01/26/2005CN1569076A Dermatosis treating medicine
01/26/2005CN1569072A Compound chinese medicinal oral preparation for treating alopecia areata and alopecia and its preparing method
01/26/2005CN1569065A Medicine for treating piles and burns
01/26/2005CN1569062A Acne treating medicine
01/26/2005CN1569058A Innovative technique for processing aloe raw material with high stability
01/26/2005CN1569038A Medicine for treating knife wound and other wounds and its preparation
01/26/2005CN1569037A Medicine for treating burns and scalds and its preparation method
01/26/2005CN1569036A Medicine for treating cindyloma acuminatum and its preparing process
01/26/2005CN1569032A Cattle bone ash made burns treating medicine
01/26/2005CN1569029A Medicine for treating recurrent psoriasis and its preparing process
01/26/2005CN1569026A Medicine for preventing and treating chilblain and its preparation method
01/26/2005CN1569025A Medicine for treating psoriasis and its preparation method
01/26/2005CN1569020A Folliculitis dermatitis cream
01/26/2005CN1569010A Etimicin sulfate preparation and its preparing method
01/26/2005CN1568978A Composition for preventing and treating whelk
01/26/2005CN1568973A Composition of vitamin C and arginine and its application
01/26/2005CN1568967A Radiation resistant medicament of ginko flavone and tea polyphenol
01/26/2005CN1568957A Reforming effect of arginine to recessive harm of skin tissue of diabetic
01/26/2005CN1568935A Skin whitening compositions containing asparagus extract
01/26/2005CN1568926A Pharmaceutical shampoo
01/26/2005CN1186332C New thryoid receptor ligands and process II
01/26/2005CN1186322C Proline derivatives and use thereof as drugs
01/26/2005CN1186090C Liquid medicine for treating burn
01/26/2005CN1186079C Burn treating medicine powder
01/26/2005CN1186077C Medicine for stopping pain, diminishing inflammation, removing necrosis and promoting granulation
01/26/2005CN1186068C Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its preparation process
01/26/2005CN1186055C Medicine for treating acne and preparing process thereof
01/26/2005CN1186047C Externally applied psoriasis treating medicine and its preparation
01/26/2005CN1186034C Chinese medicine for treating burn and scald
01/26/2005CN1185957C Skin-care agent, health and face-care foodstuff
01/25/2005US6846920 Comprises nucleotide sequences coding eosinophil protease (EOS) for preparing laundry detergents, stain-removing solutions, skin care products and treating blood and respiratory system disorders
01/25/2005US6846837 Topical administration of basic antifungal compositions to treat fungal infections of the nails
01/25/2005US6846834 Antiinflammation agents
01/25/2005US6846829 N-heterocyclic derivatives as NOS inhibitors
01/25/2005US6846828 Aminopyrimidine and aminopyridine anti-inflammation agents
01/25/2005US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents
01/25/2005US6846821 Tetrahydrothiopy ranphthalazinone derivatives as PDE4 inhibitors
01/25/2005US6846811 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer
01/25/2005US6846674 Gene, encoding a subunit of the transcription factor AP-1, of its genome is inactivated and/or a component, acting on the AP-1 transcription factor, of the signal transduction pathway is modified resulting in a modified AP-1 activity and
01/25/2005US6846499 Medical effect of jojoba oil
01/25/2005US6846494 Aftertreatment surgery; mixture of protein, carbohydrates, fats, arginine, ascorbic acid, tocophenol and flavonoids
01/25/2005US6846490 Enhance hydrophobicity of a biological surface by applying vernix and a dispersant
01/25/2005US6846485 Fish serine proteinase and their pharmaceutical and cosmetic use
01/25/2005CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes
01/20/2005WO2005006807A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone
01/20/2005WO2005006806A1 Wireless microphone communication system
01/20/2005WO2005005383A1 Amino alcohol compound
01/20/2005WO2005004914A1 MEDICINAL COMPOSITION CONTAINING NF-κB DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME
01/20/2005WO2005004913A1 Pharmaceutical composition containing decoy and method of using the same
01/20/2005WO2005004906A2 Use of dp iv and apn inhibitors for the treatment of dermatological diseases involving the hyperproliferation and modified differentiation conditions of fibroblasts
01/20/2005WO2005004894A2 Methods for increasing cell and tissue viability
01/20/2005WO2005004891A2 Use of an antioxidant in a dermatological and/or cosmetic composition
01/20/2005WO2005004858A1 Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them
01/20/2005WO2005004856A1 Antifungal composition
01/20/2005WO2005004829A1 Powdery compositions and skin preparation containing the same for external use
01/20/2005WO2004106519A3 Mrp8/mrp14 inhibitors and the use thereof for preventing and/or treating hypertrophic scars and keloids
01/20/2005WO2004069213A3 Cosmetic composition comprising a 2-alkylideneaminooxyacetamide
01/20/2005WO2004069142A3 Anti-candida agents for the treatment of prion diseases
01/20/2005WO2003062392A3 Methods of treating conditions associated with an edg receptor
01/20/2005WO2002050289A8 Methods for the production of multimeric proteins, and related compositions
01/20/2005US20050014815 Substituted 2-pyrrolidine-2-yl-1H-indole compounds
01/20/2005US20050014803 Enzyme inhibitors
01/20/2005US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
01/20/2005US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
01/20/2005US20050014781 Ring fused pyrazole derivatives as CRF antagonists
01/20/2005US20050014735 Therapy for autoimmune disease; antiallergens; antihistamines
01/20/2005US20050014731 Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds
01/20/2005US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
01/20/2005US20050014701 Synergistic mixture; anticoagulants
01/20/2005US20050014699 Combinations of enzyme inhibitor-containing preparations and the use thereof
01/20/2005US20050014696 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
01/20/2005US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes
01/20/2005US20050014242 Expression vector comprising nuclelotide sequences coding seriene protease for use as therapeutic protein in treatment of inflammatory, reproductive, epidermal and neurological tissue disorders
01/20/2005US20050014222 Phosphatases which activate map kinase pathways
01/20/2005US20050013877 Strontium compound for treatment of sub-dermal soft tissue pain
01/20/2005US20050013873 Use of glass compositions for achieving an antioxidative effect
01/20/2005US20050013858 Sustained release formulation; shorter treatment duration; higher tolerance; fungal infections
01/20/2005US20050013852 Rapid release, water permeable self adhesive polymer matrix system; photodynamic therapy and/or diagnosis of skin lesions
01/20/2005US20050013821 Mint extract and related pharmaceutical compositions
01/20/2005DE10330243A1 Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis Use of products derived from extremophilic bacteria osmolytes for the production of drugs for external treatment of atopic dermatitis
01/20/2005DE10327719A1 VEGFR-2 und VEGFR-3 Inhibitorische Anthranylamidpyridone VEGFR-2 and VEGFR-3 inhibitory Anthranylamidpyridone
01/20/2005CA2838411A1 Methods of treating acne and rosacea with galvanic generated electricity
01/20/2005CA2532828A1 Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them
01/20/2005CA2531629A1 Medicinal composition containing nf-.kappa.b decoy for treating and preventing respiratory diseases and method of using the same
01/20/2005CA2531186A1 Use of an antioxidant in a dermatological and/or cosmetic composition